Valuation: Southern Acids (M)

Market Cap 412M 101M 87.61M 82.19M 74.86M 141M 9.7B 143M 964M 378M 4.86B 381M 373M 16.17B P/E 2025
11.4x
P/E 2026 11.1x
Enterprise Value -14.29M -3.52M -3.04M -2.85M -2.6M -4.88M -337M -4.95M -33.42M -13.09M -169M -13.21M -12.93M -561M EV / Sales 2025
0.05x
EV / Sales 2026 -0.01x
Free-Float
26.2%
Yield 2025
1.64%
Yield 2026 1.65%
1 day-0.33%
1 week-0.99%
Current month-2.28%
1 month-3.23%
3 months-4.15%
6 months-8.54%
Current year-5.66%
1 week 3
Extreme 3
3.12
1 month 3
Extreme 3
3.12
Current year 2.99
Extreme 2.99
3.5
1 year 2.99
Extreme 2.99
3.6
3 years 2.82
Extreme 2.82
3.85
5 years 2.82
Extreme 2.82
4.3
10 years 2.7
Extreme 2.7
5.25
Manager TitleAgeSince
Chief Executive Officer 47 14/07/2015
Director of Finance/CFO 58 30/09/2013
Chief Tech/Sci/R&D Officer 38 15/07/2014
Director TitleAgeSince
Director/Board Member 66 09/08/2005
Director/Board Member 59 19/03/2012
Chairman 79 14/07/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%-0.99%-12.02%-14.04% 101M
+2.70%-2.03%+30.67%+391.13% 5.92B
+0.27%+3.00%+31.25%+103.23% 1.78B
+0.11%-9.11%+12.22%+71.91% 829M
+2.77%-1.46%+30.23%+14.57% 599M
-1.76%-1.62%+42.64%+103.96% 575M
+2.23%0.00%-15.41%-26.31% 522M
+4.27%+1.35%+54.38%+5.70% 417M
+0.85%+1.15%+9.29%+11.82% 395M
-2.52%+0.03%+19.08%+64.57% 290M
Average +0.86%+0.32%+20.23%+72.66% 1.14B
Weighted average by Cap. +1.72%+0.09%+27.35%+230.77%

Financials

2025 2026
Net sales 1.11B 272M 235M 221M 201M 378M 26.04B 383M 2.59B 1.01B 13.04B 1.02B 1B 43.39B 934M 230M 198M 186M 170M 319M 21.98B 323M 2.18B 855M 11.01B 863M 844M 36.63B
Net income 36.7M 9.04M 7.8M 7.32M 6.67M 12.53M 864M 12.71M 85.8M 33.62M 433M 33.93M 33.19M 1.44B 37.38M 9.2M 7.95M 7.45M 6.79M 12.77M 880M 12.94M 87.38M 34.24M 441M 34.55M 33.8M 1.47B
Net Debt -367M -90.33M -77.98M -73.16M -66.64M -125M -8.64B -127M -858M -336M -4.33B -339M -332M -14.39B -426M -105M -90.65M -85.04M -77.46M -146M -10.04B -148M -997M -391M -5.03B -394M -386M -16.73B
Logo Southern Acids (M)
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products and investments in other palm oil related sectors. The Company’s segments include Oleochemical Manufacturing, Healthcare Services, Milling & Cultivation, and Investments & Services. The Oleochemical Manufacturing Segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The Healthcare Services operates Sri Kota Specialist Medical Center (Sri Kota), a private tertiary hospital located in Klang, Selangor. The Milling & Cultivation segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (CPO) and palm kernels, as well as oil palm cultivation. Milling & Cultivation operates approximately two palm oil mills (POM) located in Riau, Indonesia with a combined milling capacity of approximately 100 metric tons (MT) per hour.
Employees
1,676
Date Price Change Volume
18/08/26 MYR 3.000 -0.33% 16,300
17/08/26 MYR 3.010 0.00% 18,100
14/08/26 MYR 3.010 0.00% 28,100
13/08/26 MYR 3.010 -0.33% 68,700
12/08/26 MYR 3.020 -0.33% 7,900
  1. Stock Market
  2. Stocks
  3. 5134 Stock